EZZ Life Science Holdings Limited

ASX:EZZ.AX

3.5 (AUD) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 44.74721.69710.84822.01811.01715.1267.5638.8084.4046.2143.1079.7234.86112.5656.2828.2484.4519.0674.534
Cost of Revenue 10.0137.143.1945.3362.324.6051.9864.8292.1443.6991.6135.0092.2845.6272.636.4443.0957.313.549
Gross Profit 34.73414.5577.65416.6828.69710.5215.5773.9792.262.5151.4944.7132.5776.9383.6521.8041.3561.7580.984
Gross Profit Ratio 0.7760.6710.7060.7580.7890.6960.7370.4520.5130.4050.4810.4850.530.5520.5810.2190.3050.1940.217
Reseach & Development Expenses 0000000000000000000
General & Administrative Expenses 00.0590.0590.0490.0490.0710.0710.060.060.0790.0790.0680.0680.010.010.0740.0740.0740.074
Selling & Marketing Expenses 05.8675.8676.3996.3993.883.880.8640.8640.6210.6211.5851.5852.3372.3370.2730.2730.5040.504
SG&A 26.51113.0646.20513.826.7338.7674.2382.3481.1652.5040.9063.6881.8435.392.4980.8620.4371.220.647
Other Expenses 0000000000000000000
Operating Expenses 26.51113.0646.90713.827.1418.7674.6952.3481.4272.5041.4353.6882.0465.392.810.8620.5471.220.716
Operating Income 8.2231.4930.7472.8621.4481.7540.8811.6310.8330.0110.0591.0250.5321.5480.8420.9430.8090.5370.269
Operating Income Ratio 0.1840.0690.0690.130.1310.1160.1170.1850.1890.0020.0190.1050.1090.1230.1340.1140.1820.0590.059
Total Other Income Expenses Net 0.210.0330.0160.2610.1130.0250.0080.033-0.0010.104-0.0010.03-0.0040.134-0.0010.674-0.001-0.004-0.002
Income Before Tax 8.4331.5260.7633.1221.5611.7780.8891.6640.8320.1160.0581.0550.5271.6820.8411.6170.8080.5330.267
Income Before Tax Ratio 0.1880.070.070.1420.1420.1180.1180.1890.1890.0190.0190.1080.1080.1340.1340.1960.1820.0590.059
Income Tax Expense 2.6110.3840.1920.7920.3960.4790.240.4510.2260.0160.0080.2470.1240.4590.2290.4030.2010.1610.081
Net Income 5.8221.1420.5712.3311.1651.2990.651.2130.6060.10.050.8080.4041.2230.6111.2140.6070.3720.186
Net Income Ratio 0.130.0530.0530.1060.1060.0860.0860.1380.1380.0160.0160.0830.0830.0970.0970.1470.1360.0410.041
EPS 0.130.0270.0130.0550.0270.030.0150.0290.0140.0020.0010.0190.0110.0290.020.02900.0090
EPS Diluted 0.130.0270.0130.0550.0270.030.0150.0290.0140.0020.0010.0190.0110.0290.020.02900.0090
EBITDA 8.4231.6850.7532.9861.4551.8120.8851.6910.8370.070.0621.0850.5361.6130.8461.0160.8250.6110.305
EBITDA Ratio 0.1880.0780.0690.1360.1320.120.1170.1920.190.0110.020.1120.110.1280.1350.1230.1850.0670.067